[{"symbol": "RGC", "price": 27.43, "beta": 2.022, "volAvg": 407470, "mktCap": 13563830746, "lastDiv": 0, "range": "0.092789-83.6", "changes": -2.63, "companyName": "Regencell Bioscience Holdings Limited", "currency": "USD", "cik": "0001829667", "isin": "KYG7487R1002", "cusip": "G7487R100", "exchange": "NASDAQ Capital Market", "exchangeShortName": "NASDAQ", "industry": "Drug Manufacturers - Specialty & Generic", "website": "https://www.regencellbioscience.com", "description": "Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.", "ceo": "Yat-Gai Au", "sector": "Healthcare", "country": "HK", "fullTimeEmployees": "12", "phone": "852 2155 0823", "address": "First Commercial Building", "city": "Causeway Bay", "state": null, "zip": "KY1-1107", "dcfDiff": 27.42621, "dcf": 0.003791187162483329, "image": "https://images.financialmodelingprep.com/symbol/RGC.png", "ipoDate": "2021-07-16", "defaultImage": false, "isEtf": false, "isActivelyTrading": true, "isAdr": false, "isFund": false}]